Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5596 AL 5610

The functional neurophysiology of the amyloid precursor protein (APP) processing pathway

Randall AD, Witton J, Booth C, Hynes-Allen A, Brown JT.

Neuropharmacology. 2010 Sep-Oct;59(4-5):243-67. doi: 10.1016/j.neuropharm.2010.02.011. Epub 2010 Feb 16.

Diagnosis of prodromal Alzheimer's disease: do you really want to know?

Gauthier S, Leuzy A.

Can J Neurol Sci. 2010 Jan;37(1):2. doi: 10.1017/s0317167100009574.

Diagnosis disclosure of prodromal Alzheimer disease-ethical analysis of two cases

Porteri C, Galluzzi S, Geroldi C, Frisoni GB.

Can J Neurol Sci. 2010 Jan;37(1):67-75. doi: 10.1017/s0317167100009677.

Vascular dementia and Alzheimer's disease - are we in a dead-end road?

Cavalieri M, Enzinger C, Petrovic K, Pluta-Fuerst A, Homayoon N, Schmidt H, Fazekas F, Schmidt R.

Neurodegener Dis. 2010;7(1-3):122-6. doi: 10.1159/000285521. Epub 2010 Feb 18.

Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging

Mosconi L, Berti V, Glodzik L, Pupi A, De Santi S, de Leon MJ.

J Alzheimers Dis. 2010;20(3):843-54. doi: 10.3233/JAD-2010-091504.

Translational research in genomics of Alzheimer's disease: a review of current practice and future perspectives

Mihaescu R, Detmar SB, Cornel MC, van der Flier WM, Heutink P, Hol EM, Rikkert MG, van Duijn CM, Janssens AC.

J Alzheimers Dis. 2010;20(4):967-80. doi: 10.3233/JAD-2010-1410.

[Institutionalization of mentally ill in old age]

Riedel-Heller SG, Luppa M, König HH.

Psychiatr Prax. 2010 Mar;37(2):53-5. doi: 10.1055/s-0029-1223514. Epub 2010 Feb 24.

Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice

Hayashi Y, Ishida Y, Inoue T, Udagawa M, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Sameshima T, Kawahara T, Goto I, Shudo K, Kurayama S, Nakamura J, Okahara K, Mitsuyama Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 16;34(3):541-5. doi: 10.1016/j.pnpbp.2010.02.016. Epub 2010 Feb 23.

Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease

Cumbo E, Ligori LD.

Epilepsy Behav. 2010 Apr;17(4):461-6. doi: 10.1016/j.yebeh.2010.01.015. Epub 2010 Feb 25.

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA, Rodriguez Martinez de Liano S, Liu E, Koller M, Gregg KM, Schenk D, Black R, Grundman M.

Lancet Neurol. 2010 Apr;9(4):363-72. doi: 10.1016/S1474-4422(10)70043-0. Epub 2010 Feb 26.

Non-pharmacologic management of sleep disturbance in Alzheimer's disease

David R, Zeitzer J, Friedman L, Noda A, O'Hara R, Robert P, Yesavage JA.

J Nutr Health Aging. 2010 Mar;14(3):203-6. doi: 10.1007/s12603-010-0050-9.

Early detection of Alzheimer's disease with PET imaging

Berti V, Osorio RS, Mosconi L, Li Y, De Santi S, de Leon MJ.

Neurodegener Dis. 2010;7(1-3):131-5. doi: 10.1159/000289222. Epub 2010 Mar 3.

Clinical trial efforts in Alzheimer disease: why test statins?

Arvanitakis Z, Knopman DS.

Neurology. 2010 Mar 23;74(12):945-6. doi: 10.1212/WNL.0b013e3181d6479a. Epub 2010 Mar 3.

Magnetoencephalography in neuropsychiatry: ready for application?

Williams MA, Sachdev PS.

Curr Opin Psychiatry. 2010 May;23(3):273-7. doi: 10.1097/YCO.0b013e328338621d.

Values of default mode network to Alzheimer's disease call for consilience of multimodal neuroimaging and genetics

Hou B, Xu L.

J Neurosci. 2010 Mar 10;30(10):3553-4. doi: 10.1523/JNEUROSCI.6008-09.2010.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias